Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and fallout of the EU/AstraZeneca…

The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest…

The shockwaves from the UK's exit from the European Union have resounded across the continent, including in Turkey, where the country's pharmaceutical…

The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed by the UK pharma industry, which…

US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central London, with plans to open the…

Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare…

Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British Prime Minister Boris Johnson’s…

Although biotech financing in the UK took a hit last year in large part thanks to uncertainty around Brexit, 2019 was still the British industry's…

Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

Aditya Bhattacharji takes a look at the potentially damaging impact of political uncertainty across Europe - including the impending exit of the UK…

The 9th February 2019 marked the launch of the European Medicines Verification System (EMVS) which will use cutting-edge technology to safeguard the…

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK patients. The plan is…